← Back to ETF Screener

State Street SPDR S&P Biotech ETF

XBI Sector

Updated: May 20, 2026, 21:17 UTC

$131.71
+3.88% today
52W: $78.00 – $139.19
52W Low: $78.00 Position: 87.8% 52W High: $139.19

Key Metrics

Expense Ratio (TER)
0.35%
Annual total expense ratio
Assets Under Management
$8.3B
Total managed assets
Dividend Yield
0.34%
Annual distribution yield
YTD Return
+8.39%
Year-to-date performance
3-Year Return (ann.)
+14.29%
Average annual (3 years)
5-Year Return (ann.)
+0.4%
Average annual (5 years)

Top 10 Holdings

Holding Ticker Weight Bar
Apellis Pharmaceuticals Inc APLS 1.87%
Revolution Medicines Inc Ordinary Shares RVMD 1.65%
Travere Therapeutics Inc Ordinary Shares TVTX 1.62%
Arrowhead Pharmaceuticals Inc ARWR 1.44%
Twist Bioscience Corp TWST 1.42%
Summit Therapeutics Inc Ordinary Shares SMMT 1.4%
Alkermes PLC ALKS 1.38%
TG Therapeutics Inc TGTX 1.37%
Madrigal Pharmaceuticals Inc MDGL 1.36%
Beam Therapeutics Inc BEAM 1.32%

Sector Allocation

Healthcare 99.8%
Financial Services 0.2%

About This ETF

The State Street SPDR S&P Biotech ETF (XBI) is a Sector ETF with an expense ratio (TER) of 0.35% and $8.3B in assets under management., with its largest holdings being Apellis Pharmaceuticals Inc, Revolution Medicines Inc Ordinary Shares, Travere Therapeutics Inc Ordinary Shares. The ETF currently yields 0.34% in dividends. Year-to-date, XBI has returned +8.39%.

In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI").

Category: Sector Exchange: PCX Currency: USD

🔄 Compare XBI with:

FAQ — XBI

What is the TER of XBI (State Street SPDR S&P Biotech ETF)?

XBI has a Total Expense Ratio (TER) of 0.35 % per year. That sits above the sector category median (0.08 % across 13 peer ETFs). The TER is deducted directly from the fund and lowers your effective return.

What return has XBI delivered?

Performance for XBI: YTD: +8.39 % · 3-year p.a.: +14.29 % · 5-year p.a.: +0.40 %. Over 5 years, XBI underperforms the sector category median of +8.43 % by -8.03 pp. Past performance is no guarantee of future returns.

What are the top holdings of XBI?

The five largest positions in XBI are: APLS, RVMD, TVTX, ARWR, TWST. The full holdings list is updated daily on this page.

Does XBI pay dividends?

XBI has a current dividend yield of 0.34 %. Distributing ETFs pay this out in cash; accumulating versions reinvest it inside the fund. Check the share class on your broker before buying.

Where can I buy or set up a savings plan for XBI?

XBI is available at most major brokers. For a free monthly savings plan from €1, look at Trade Republic, Scalable Capital or Flatex. The broker comparison on this site shows fees, free-savings-plan ETFs and execution exchanges side by side.

Where can I buy XBI?

Compare the best brokers for ETF savings plans — low fees, trusted providers, fully regulated.

Scroll to Top
WordPress Cookie Notice by Real Cookie Banner